Mereo Biopharma Group PLC
NASDAQ:MREO

Watchlist Manager
Mereo Biopharma Group PLC Logo
Mereo Biopharma Group PLC
NASDAQ:MREO
Watchlist
Price: 3.2 USD -2.14% Market Closed
Updated: May 19, 2024

Mereo Biopharma Group PLC
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Mereo Biopharma Group PLC
Additional Paid In Capital Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Mereo Biopharma Group PLC
NASDAQ:MREO
Additional Paid In Capital
£254.3m
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Additional Paid In Capital
$987.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Additional Paid In Capital
$1B
CAGR 3-Years
20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Additional Paid In Capital
$894.6m
CAGR 3-Years
42%
CAGR 5-Years
236%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Additional Paid In Capital
£1.1B
CAGR 3-Years
N/A
CAGR 5-Years
39%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Additional Paid In Capital
£179.1m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
5%

See Also

What is Mereo Biopharma Group PLC's Additional Paid In Capital?
Additional Paid In Capital
254.3m GBP

Based on the financial report for Dec 31, 2022, Mereo Biopharma Group PLC's Additional Paid In Capital amounts to 254.3m GBP.

What is Mereo Biopharma Group PLC's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 3Y
28%

Over the last year, the Additional Paid In Capital growth was 3%. The average annual Additional Paid In Capital growth rates for Mereo Biopharma Group PLC have been 28% over the past three years .